Physician profile
John W Evans
NPI 1033152525
$1,399.74
in general payments reported to CMS, 2019-2025
31 companies · $131 in 2025
The $131 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $342 · 2020: $99.40 · 2021: $29.34 · 2022: $217 · 2023: $199 · 2024: $383 · 2025: $131.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $713.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $712.85 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Davol INC. | $195.20 | 2019-2024 | Phasix Mesh |
| Intuitive Surgical, INC. | $98.89 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $87.82 | 2019-2024 | Imfinzi |
| Melinta Therapeutics, LLC | $66.34 | 2019-2020 | |
| Medtronic, INC. | $65.34 | 2023-2024 | Signia, Pteye Parathyroid Detection System, Interstim |
| Vertex Pharmaceuticals Incorporated | $62.87 | 2025 | |
| Merck Sharp & Dohme LLC | $60.95 | 2019 | |
| Polynovo North America LLC | $56.02 | 2022 | |
| Smith+Nephew, INC. | $54.08 | 2020-2022 | |
| Kerecis Limited | $47.86 | 2023-2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Endogastric Solutions, INC | $46.83 | 2024 | Esophyx |
| Baxter Healthcare | $46.65 | 2019-2022 | |
| Myriad Genetic Laboratories, INC. | $46.02 | 2021-2022 | |
| E.R. Squibb & Sons, L.L.C. | $40.75 | 2022-2023 | |
| Urgo Medical North America, LLC | $39.24 | 2024-2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Integra Lifesciences Corporation | $37.18 | 2022-2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Kci USA, INC. | $34.91 | 2020-2023 | Activ.A.C., V.A.C. Dermatac, Promogran Prisma |
| Musculoskeletal Transplant Foundation INC. | $33.13 | 2022 | |
| Novartis Pharmaceuticals Corporation | $29.45 | 2025 | |
| Lemaitre Vascular, INC. | $28.71 | 2023 | Artegraft Vascular Graft |
| Silk Road Medical, INC. | $26.66 | 2024 | Enroute Transcarotid Neuroprotection System, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter, Enroute Transcarotid Stent |
| Braintree Laboratories, INC. | $26.56 | 2022 | |
| Stryker Corporation | $25.00 | 2023 | Spy-Phi System |
| Ethicon US, LLC | $21.22 | 2024 | Echelon; Endopath, Echelon Endopath |
| Abbvie INC. | $20.71 | 2022 | |
| Incyte Corporation | $20.15 | 2025 | Jakafi |
| Acera Surgical, INC. | $20.10 | 2019 | |
| Osiris Therapeutics INC. | $17.53 | 2019 | |
| Tactile Systems Technology INC | $15.75 | 2023 | Flexitouch Plus, Entre Plus |
| Covidien LP | $14.68 | 2020 | |
| Cumberland Pharmaceuticals, INC. | $13.14 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Evans listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.